跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
METALYSE tenecteplase (rch) 25 mg powder for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
METALYSE tenecteplase (rch) 25 mg powder for injection vial
Approved
STANDARD
METALYSE tenecteplase (rch) 25 mg powder for injection vial
Boehringer Ingelheim Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Jul 18, 2025
Approval ID
c9e50a0f3b4e7007
Company
Boehringer Ingelheim Pty Ltd
Type
Standard
Approval Details
Approval Id
c9e50a0f3b4e7007
Product Name
METALYSE tenecteplase (rch) 25 mg powder for injection vial
Artg Id
443530
Artg Name
METALYSE tenecteplase (rch) 25 mg powder for injection vial
Sponsor
Boehringer Ingelheim Pty Ltd
Company Detail Path
/organization/boehringer-ingelheim-pty-ltd
Artg Date
2025-07-15
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Jul 18, 2025
Approval ID
c9e50a0f3b4e7007
Type
Standard
Back to TGA Approvals
